Therefore, the therapeutic effects of OVA@SVMAV combined with anti-programmed cell death protein 1 antibody (aPD-1) were investigated in mice bearing melanoma exogenously expressing OVA following the treatment scheme shown in figure 6A. Here, PDCD1 is linked to melanoma.